Perioperative chemotherapy for gastric cancer: how should we measure the efficacy?

Roberto Persiani; Stefano Rausei; Alberto Biondi; Domenico D'Ugo

doi:10.1245/s10434-008-0310-7

Perioperative chemotherapy for gastric cancer: how should we measure the efficacy?

Roberto Persiani, Stefano Rausei, Alberto Biondi, Domenico D'Ugo

Risultato della ricerca: Contributo in rivista › Articolo in rivista

3 Citazioni (Scopus)

Abstract

No abstract

Lingua originale	English
pagine (da-a)	1077-1079
Numero di pagine	3
Rivista	Annals of Surgical Oncology
Volume	16
DOI	https://doi.org/10.1245/s10434-008-0310-7
Stato di pubblicazione	Pubblicato - 2009

Keywords

Antineoplastic Agents
Chemotherapy, Adjuvant
Humans
Neoadjuvant Therapy
Patient Selection
Perioperative Care
Stomach Neoplasms
Treatment Outcome

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1245/s10434-008-0310-7

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{e44a019ab55c4205a0bf9ae90cedfbdc,

title = "Perioperative chemotherapy for gastric cancer: how should we measure the efficacy?",

abstract = "No abstract",

keywords = "Antineoplastic Agents, Chemotherapy, Adjuvant, Humans, Neoadjuvant Therapy, Patient Selection, Perioperative Care, Stomach Neoplasms, Treatment Outcome, Antineoplastic Agents, Chemotherapy, Adjuvant, Humans, Neoadjuvant Therapy, Patient Selection, Perioperative Care, Stomach Neoplasms, Treatment Outcome",

author = "Roberto Persiani and Stefano Rausei and Alberto Biondi and Domenico D'Ugo",

year = "2009",

doi = "10.1245/s10434-008-0310-7",

language = "English",

volume = "16",

pages = "1077--1079",

journal = "Annals of Surgical Oncology",